Web Stats Provided By Google Analytics

Saturday, December 2, 2017

CymaBay Therapeutics Inc Expected to Earn FY2019 Earnings of

... North America L.P. bought a new position in CymaBay Therapeutics during the second quarter worth about $242,000. Ardsley Advisory Partners lifted its holdings in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2noMdYC

No comments:

Post a Comment

Popular Ardsley Roundup Posts